630
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Ferrostatin-1 improves prognosis and regulates gut microbiota of steatotic liver transplantation recipients in rats

, , , , , & show all
Pages 413-429 | Received 09 Jun 2023, Accepted 15 Nov 2023, Published online: 02 Feb 2024

References

  • Schlegel A , van ReevenM , CroomeKet al. A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation. J. Hepatol.76(2), 371–382 (2022).
  • Goldaracena N , CullenJM , KimD-S , EkserB , HalazunKJ. Expanding the donor pool for liver transplantation with marginal donors. Int. J. Surg.82S, 30–35 (2020).
  • Yang X , LuD , WangRet al. Single-cell profiling reveals distinct immune phenotypes that contribute to ischaemia-reperfusion injury after steatotic liver transplantation. Cell Prolif.54(10), e13116 (2021).
  • Hann A , Osei-BordomD-C , NeilDAH , RoncaV , WarnerS , PereraMTPR. The human immune response to cadaveric and living donor liver allografts. Front. Immunol.11, 1227 (2020).
  • Patrono D , DeStefano N , VissioEet al. How to preserve steatotic liver grafts for transplantation. J. Clin. Med.12(12), 3982 (2023).
  • Ancona G , AlagnaL , LombardiAet al. The interplay between gut microbiota and the immune system in liver transplant recipients and its role in infections. Infect. Immun.89(11), e0037621 (2021).
  • Liu Y , MéricG , HavulinnaASet al. Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting. Cell Metab.34(5), 719–730 (2022).
  • Watt KD . The evolving role of the microbiome in liver failure and liver transplantation. Liver Transpl.22(Suppl. 1), 58–61 (2016).
  • Wu Z-W , LingZ-X , LuH-Fet al. Changes of gut bacteria and immune parameters in liver transplant recipients. Hepatobiliary Pancreat. Dis. Int.11(1), 40–50 (2012).
  • Ianiro G , SegalJP , MullishBHet al. Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders. Future Microbiol.15, 1173–1183 (2020).
  • Kelly D , ConwayS , AminovR. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol.26(6), 326–333 (2005).
  • Bajaj JS , FaganA , SikaroodiMet al. Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. Liver Transpl.23(7), 907–914 (2017).
  • Yuan M , LinL , CaoHet al. Intestinal microbiota participates in the protective effect of HO-1/BMMSCs on liver transplantation with steatotic liver grafts in rats. Front. Microbiol.13, 905567 (2022).
  • Annavajhala MK , Gomez-SimmondsA , MacesicNet al. Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation. Nat. Commun.10(1), 4715 (2019).
  • Zhang H , ZhangE , HuH. Role of ferroptosis in non-alcoholic fatty liver disease and its implications for therapeutic strategies. Biomedicines9(11), 1660 (2021).
  • Chen J , LiX , GeC , MinJ , WangF. The multifaceted role of ferroptosis in liver disease. Cell Death Differ.29(3), 467–480 (2022).
  • Nelson JE , WilsonL , BruntEMet al. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology53(2), 448–457 (2011).
  • Chen Y , FanH , WangS , TangG , ZhaiC , ShenL. Ferroptosis: a novel therapeutic target for ischemia-reperfusion injury. Front. Cell. Dev. Biol.9, 688605 (2021).
  • Li X , WuL , TianXet al. miR-29a-3p in exosomes from heme oxygenase-1 modified bone marrow mesenchymal stem cells alleviates steatotic liver ischemia-reperfusion injury in rats by suppressing ferroptosis via iron responsive element binding protein 2. Oxid. Med. Cell Longev.2022, 6520789 (2022).
  • Wu L , TianX , ZuoHet al. miR-124-3p delivered by exosomes from heme oxygenase-1 modified bone marrow mesenchymal stem cells inhibits ferroptosis to attenuate ischemia-reperfusion injury in steatotic grafts. J. Nanobiotechnol.20(1), 196 (2022).
  • Cao H , WuL , TianXet al. HO-1/BMMSC perfusion using a normothermic machine perfusion system reduces the acute rejection of DCD liver transplantation by regulating NKT cell co-inhibitory receptors in rats. Stem Cell Res. Ther.12(1), 587 (2021).
  • Neri A-A , DontasIA , IliopoulosDC , KaratzasT. Pathophysiological changes during ischemia-reperfusion injury in rodent hepatic steatosis. In Vivo34(3), 953–964 (2020).
  • Guicciardi ME , MalhiH , MottJL , GoresGJ. Apoptosis and necrosis in the liver. Compr. Physiol.3(2), 977– 1010 (2013).
  • Mu J , ChenQ , ZhuLet al. Influence of gut microbiota and intestinal barrier on enterogenic infection after liver transplantation. Curr. Med. Res. Opin.35(2), 241–248 (2019).
  • Li S-P , ZhangJ-M , ChenX-Jet al. Characteristics of changes in double positive CD4CD8 T cells in liver transplantation. Int. Immunopharmacol.110, 109028 (2022).
  • Schuster S , CabreraD , ArreseM , FeldsteinAE. Triggering and resolution of inflammation in NASH. Nat. Rev. Gastroenterol. Hepatol.15(6), 349–364 (2018).
  • Deng F , ZhaoB-C , YangXet al. The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis. Gut Microbes13(1), 1–21 (2021).
  • Tarantino G , FinelliC. Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease. Future Microbiol10(5), 889–902 (2015).
  • Liu B , PanX , LiuZet al. Fecal microbiota as a noninvasive biomarker to predict the tissue iron accumulation in intestine epithelial cells and liver. FASEB J.34(2), 3006–3020 (2020).
  • Liang D , LeungRK-K , GuanW , AuWW. Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities. Gut Pathog.10, 3 (2018).
  • Rossi E , LongoF , BarbagalloMet al. Glucose availability enhances lipopolysaccharide production and immunogenicity in the opportunistic pathogen Acinetobacter baumannii. Future Microbiol.11(3), 335–349 (2016).
  • Lang S , SchnablB. Microbiota and fatty liver disease-the known, the unknown, and the future. Cell Host Microbe28(2), 233–244 (2020).
  • Zhang F , ChenD , ZhangLet al. Diaphragma juglandis extracts modifies the gut microbiota during prevention of type 2 diabetes in rats. J. Ethnopharmacol.283, 114484 (2022).
  • Liang H , SongH , ZhangXet al. Metformin attenuated sepsis-related liver injury by modulating gut microbiota. Emerg. Microbes. Infect.11(1), 815–828 (2022).
  • Yuan G , TanM , ChenX. Punicic acid ameliorates obesity and liver steatosis by regulating gut microbiota composition in mice. Food Funct.12(17), 7897–7908 (2021).
  • Ren Z , FanH , GuSet al. Expression analysis and the roles of the sec1 gene in regulating the composition of mouse gut microbiota. Genes (Basel)13(10), 1858 (2022).
  • Bajaj JS , KhorutsA. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. J. Hepatol.72(5), 1003–1027 (2020).
  • Koh A , DeVadder F , Kovatcheva-DatcharyP , BäckhedF. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell165(6), 1332–1345 (2016).
  • Liu P , WangY , YangGet al. The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis. Pharmacol. Res.165, 105420 (2021).
  • Salvi PS , CowlesRA. Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells10(7), (2021).
  • Das NK , SchwartzAJ , BarthelGet al. Microbial metabolite signaling is required for systemic iron homeostasis. Cell Metab.31(1), 115–130 (2020).
  • Mayneris-Perxachs J , CardelliniM , HoylesLet al. Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome. Microbiome9(1), 104 (2021).